Perry Michael D, Evans Martin J, Byrd Philip J, Taylor Malcolm R
Department of Medical Education, St George's Hospital Medical School, University of London, London, United Kingdom.
Department of Postgraduate Medical Education, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
J Pediatr Genet. 2020 Jul 20;10(4):311-314. doi: 10.1055/s-0040-1713909. eCollection 2021 Dec.
Ataxia with oculomotor apraxia type 2 (AOA2) is a slowly progressive, autosomal recessive disease characterized by the triad of ataxia, oculomotor apraxia, and sensorimotor neuropathy. The genetic basis of AOA2 is biallelic mutation of the gene, resulting in reduced or absent senataxin, a DNA/RNA repair protein essential for genomic stability. In this case report, we described a case of AOA2 with two clear pathogenic mutations, one of which is novel. We then discussed two further likely "in cis" sequence changes (previously reported in the literature as pathogenic), and presented the case that they are likely benign polymorphisms.
2型伴动眼神经失用性共济失调(AOA2)是一种缓慢进展的常染色体隐性疾病,其特征为共济失调、动眼神经失用和感觉运动神经病三联征。AOA2的遗传基础是该基因的双等位基因突变,导致senataxin减少或缺失,senataxin是一种对基因组稳定性至关重要的DNA/RNA修复蛋白。在本病例报告中,我们描述了一例具有两个明确致病突变的AOA2病例,其中一个是新发现的突变。然后,我们讨论了另外两个可能的“顺式”序列变化(先前文献报道为致病),并提出它们可能是良性多态性的观点。